Singulex, Inc. provides immunoassay systems, which includes benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and software to automatically analyze data and display detailed assay reports.

Technology Singulex, Inc. provides immunoassay systems, which includes benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and software to automatically analyze data and display detailed assay reports. Singulex’s proprietary Single Molecule Counting technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. This technology and patents will go for public auction on July 29, 2019 at 11AM in Palo Alto, CA. Please email msaperstein@pesco.com for further details.